Bladder preserving approach for muscle invasive bladder cancer--role of mycobacterium w.

Abstract

Mycobacterium w (immuvac), a new potent immunomodulator was evaluated as concomitant therapy in the management of muscle invasive bladder cancer along with external beam radiation therapy. There was no residual tumour in all the five patients after two months of therapy. All patients remained disease free for an observation period of more than 2 years.

• Authors: Prabir Chaudhuri, Sharadwat Mukhopadhyay
• Journal: Journal of the Indian Medical Association (J Indian Med Assoc) Vol. 101 Issue 9 Pg. 559-60 (Sep 2003) ISSN: 0019-5847 [Print] India
• PMID: 15168998 (Publication Type: Clinical Trial, Journal Article)

Chemical References

• Bacterial Vaccines
• Mycobacterium w vaccine

Topics

• Bacterial Vaccines (administration & dosage)
• Carcinoma, Transitional Cell (immunology, pathology, therapy)
• Combined Modality Therapy
• Female
• Humans
• Male
• Middle Aged
• Muscle, Smooth (drug effects, pathology, radiation effects)
• Mycobacterium
• Pilot Projects
• Urinary Bladder Neoplasms (immunology, pathology, therapy)